SUMMARY Salicylate concentrations in 3819 sera of apparently healthy voluntary blood donors were determined in view of the significance of this drug in the induction of allergic reactions and its possible interference in platelet function. Two hundred and ninety-five sera were found by a modified colorimetric determination to contain salicylates. The colorimetric determination was compared with a high performance liquid chromatography (HPLC) analysis of salicylate-containing sera. Drug concentrations detected were mostly in the range of 20-100 mg/l. Such concentrations have been reported to evoke allergic reactions and to affect the haemostatic action of platelets.
The blood bank of almost any large hospital is often faced with the problem of a transfusion reaction in a patient receiving a unit of blood or one of its components-for example, packed cells, fresh frozen plasma, cryoprecipitate or platelets. Mild transfusion reactions are characterised by weals, itching, splotchy erythema, tachycardia and, very rarely, fever.' More severe transfusion reactions-though not common, yet unpleasant for both patient and treating physician-are shock-like reactions: hypertension, flushing, wheezing, dyspnoea, abdominal and back pains, frequently chest pains, cyanosis and nausea. These reactions occur within minutes of the commencement of the transfusion.2 3 The unit of blood or its component which apparently caused the reaction is returned to the blood bank, together with a fresh sample of the patient's blood, drawn after the onset of the transfusion reaction. 4 The first step undertaken in the blood bank on such occasions is the performance of a direct antiglobulin test, aimed at detecting red cells coated with antibody, which would be present in cases in which mismatched blood has been transfused. The next step would be a repeat screening of the patient's serum for antibodies which might have been missed by the first screening, together with a repeated cross match of the patient's serum with the donor's red cells. Commonly, all these tests prove to be negative. 5 Another possible reason for transfusion reactions of the anaphylactoid type is the transfusion of blood Accepted for publication 20 May 1981 or plasma containing IgA to a patient who lacks this immunoglobulin. 6 Transfusion reactions may also be caused by antibodies directed against antigens present on human leucocytes and platelets. These reactions of the anti-HLA (human leucocytic antigens) antibodies are common in patients with chronic diseases who receive transfusions regularly. The 
Material and methods
Blood plasma samples were screened for salicylates by the rapid colorimetric method of Trinder,12 as adapted by Hanok.13 The preparation of the colour reagent was modified; instead of first dissolving mercuric chloride in hot water, which could lead to the hazardous sublimation of mercuric chloride, advantage was taken of its increased solubility in acidic solution. Hydrochloric acid (120 ml 1 N) was added to 850 ml of deionised water; 40 g of mercuric chloride were added with vigorous stirring for 30 min at room temperature, followed by 40 g of ferric nitrate (9.H20). The volume was then adjusted to one litre with deionised water. All reagents were of analytical grade.
The Hanok method'3 used 0 1 ml serum or plasma and 4-0 ml of colour reagent. The purple colour which developed in the presence of salicylates was read with special long light path cuvettes. This method was further modified by us so that use could be made of regular 1-0 cm light path cuvettes. This was achieved by the addition of 4 0 ml of the above colour reagent to 0-4 ml plasma samples. The colour which was generated was linear in the range of 50-300 mg/l salicylic acid and stable for at least 75 min at room temperature. Even concentrations of 20 In a recent case in our hospital, a 25-year-old woman suffering from postpartum haemorrhage developed urticaria and pruritus during the transfusion of a single unit of blood. This adverse effect could not be attributed to mismatching of blood types or to the presence of antibiotics. However, the blood unit was found to contain about 20 mg/l aspirin. The patient was unaware of any aspirin intolerance, but a mast cell degranulation test19 proved her to be allergic to this drug.
A variety of salicylate concentrations have also been implicated in disturbances of the haemostatic effect of platelets.20 21 This fact is important, since one of the main objectives of a hospital blood bank is aiding the physician in the prevention or elimination of problems of blood clotting, either before or during an operation. The blood components most commonly used for that purpose are platelets which were separated from a blood unit within four hours of donation. While an adult thrombopaenic patient usually receives a pool of six units of platelet concentrates which, due to the dilution, may reduce the effect of salicylate on platelet function, neonates may receive only a single unit of platelet concentrate (30-50 ml by volume) and in a case where this happened to contain salicylates, it could be defective. Another high-risk patient population consists of those who are subjected to frequent transfusionsfor example, haemophiliac patients or patients suffering from thalassaemia.
Platelets have to be used within 72 h of blood donation, while whole blood or packed red blood cells can be administered within 21 days. Cryoprecipitate (antihaemophilic factor) or fresh frozen plasma, on the other hand, may be kept frozen and used after two years if stored at -20°C to -400C or after an even longer period of time, if stored at -700C. These standard practices of blood banks emphasise the need for a routine salicylate screening of sera in view of the chemical stability of salicylic acid under such storage conditions. As even trace amounts of salicylate may cause allergies, the elimination of salicylic acid-containing blood units is strongly advocated. For that purpose, the establishment of a screening routine for salicylates in blood units is recommended.
The colorimetric method, as performed in this study, can easily be used for fast, routine screening of large quantities of blood units employing standard laboratory equipment. The reliability of this method was checked by comparison with the much slower and more tedious, but very accurate and more sensitive quantification by the HPLC. This methodology appears to have adequate sensitivity for the minute quantities of salicylate which are enough to elicit a relatively mild allergic reaction, as in the case described above. We found the colorimetric reaction to be reliable for the qualitative detection of salicylic acid in sera, with no false-positive results being produced. As far as quantification was concerned, inconsistencies were detected between the two procedures ( Figure) . This, however, is of academic significance only; for practical purposes the mere detection of salicylate in the blood unit is the most important consideration. The high performance liquid chromatography, though not always routine in blood banks, could, however, be the analytical method chosen whenever interference by salicylate is suspected after the administration of an ineffective thrombocyte transfusion.
On the basis of the above discussion, we conclude that a routine prevention measure to eliminate salicylate transfusion can be carried out by colorimetric screening of donors' sera. In institutions where such a measure is not routine practice, precautions should be taken by performing salicylate analysis of blood units which are prepared for transfusion to asthmatic patients, patients known to suffer from aspirin hypersensitivity, or for platelet concentrates prepared for transfusion to thrombopaenic neonates.
In view of the high incidence of salicylates which we detected among blood donors. the screening of donor sera for other drugs which could be harmful to recipients might be of interest. 
